EDGYN participates to the Pharmacovigilance conference in Boston.
Learn more about EDGYN's vision and expertise at the Pharmacovigilance conference
This conference is an opportunity to discuss and debate with market experts on various strategic topics related to brand protection in the pharmaceutical industry.
For this occasion, Camille DISS, CPO of EDGYN will host a conference to discuss and present how the fingerprint technology has replaced physical solutions for brand protection in the pharmaceutical field.
To learn more about our fingerprinting technologies, or our implementations in the pharmaceutical field: